IRIS
MAZZOLA, ROSARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.940
AS - Asia 1.393
EU - Europa 698
SA - Sud America 393
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.460
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.885
SG - Singapore 798
DE - Germania 467
BR - Brasile 319
CN - Cina 190
VN - Vietnam 188
HK - Hong Kong 86
IT - Italia 51
FR - Francia 36
GB - Regno Unito 31
IN - India 28
MX - Messico 27
AR - Argentina 26
BD - Bangladesh 19
FI - Finlandia 16
IQ - Iraq 15
AT - Austria 14
EC - Ecuador 14
RU - Federazione Russa 13
CA - Canada 12
NL - Olanda 11
ZA - Sudafrica 11
ID - Indonesia 10
IE - Irlanda 10
UZ - Uzbekistan 10
NG - Nigeria 9
UA - Ucraina 9
CO - Colombia 8
PK - Pakistan 7
PL - Polonia 7
SE - Svezia 7
VE - Venezuela 7
PY - Paraguay 6
CL - Cile 5
MA - Marocco 5
PE - Perù 5
AL - Albania 4
GT - Guatemala 4
JM - Giamaica 4
LB - Libano 4
NP - Nepal 4
TR - Turchia 4
BB - Barbados 3
BG - Bulgaria 3
ES - Italia 3
JP - Giappone 3
MY - Malesia 3
OM - Oman 3
PH - Filippine 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
KE - Kenya 2
KR - Corea 2
LT - Lituania 2
MT - Malta 2
PT - Portogallo 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
PA - Panama 1
RO - Romania 1
SR - Suriname 1
TH - Thailandia 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.460
Salva come PNG Salva come JPEG
Città #
Dallas 1.861
Falkenstein 420
Singapore 325
San Jose 180
Ashburn 168
The Dalles 127
Hong Kong 84
Beijing 63
Ho Chi Minh City 60
Wilmington 59
Chandler 55
Hanoi 47
Shanghai 43
New York 30
Los Angeles 26
São Paulo 25
Ann Arbor 23
San Mateo 22
Santa Clara 20
Orem 19
Helsinki 16
Mexico City 15
Naples 15
Belo Horizonte 11
Lawrence 11
Leawood 11
Princeton 11
Boardman 10
Da Nang 10
Dublin 10
Fairfield 10
London 10
Benin City 9
Düsseldorf 9
Frankfurt am Main 9
Tashkent 9
Chennai 8
Nuremberg 8
Amsterdam 7
Johannesburg 7
Milan 7
Rio de Janeiro 7
Salvador 7
Woodbridge 7
Baghdad 6
Montes Claros 6
Portsmouth 6
Brooklyn 5
Curitiba 5
Denver 5
Fortaleza 5
Guarulhos 5
Haiphong 5
Hillsboro 5
Lahore 5
Porto Alegre 5
Warsaw 5
Can Tho 4
Chicago 4
Cologno Monzese 4
Dhaka 4
Florence 4
Goiânia 4
Guayaquil 4
Joinville 4
Marília 4
Montreal 4
Paris 4
Quito 4
Rome 4
Secaucus 4
Vienna 4
Asunción 3
Beirut 3
Boston 3
Bridgetown 3
Charlotte 3
Cleveland 3
Erbil 3
Guatemala City 3
Jundiaí 3
Kuala Lumpur 3
La Plata 3
Lauterbourg 3
Manchester 3
Memphis 3
Mumbai 3
Muscat 3
Newark 3
Pisa 3
Recife 3
Reston 3
Rondonópolis 3
Santa Fe 3
Santos 3
São José dos Campos 3
Taubaté 3
Tirana 3
Ankara 2
Aparecida de Goiânia 2
Totale 4.101
Salva come PNG Salva come JPEG
Nome #
1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients 638
1.5 T MR-Guided Daily Adapted SBRT on Lymph Node Oligometastases from Prostate Cancer 628
1.5T MR-Guided Daily Adaptive Stereotactic Body Radiotherapy for Prostate Re-Irradiation: A Preliminary Report of Toxicity and Clinical Outcomes 621
1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment 585
Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy 100
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 99
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 85
Can thoracic nodes oligometastases be safely treated with image guided hypofractionated radiation therapy? 84
Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease 81
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. 81
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 79
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 79
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study) 73
Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer. 68
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 65
METASTASES-DIRECTED STEREOTACTIC RADIOTHERAPY FOR OLIGOMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER: MULTICENTRE SERIES OF 86 PATIENTS/117 LESIONS 63
Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy 62
Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes 61
Stereotactic radiosurgery for intracranial metastases: linac-based and gamma-dedicated unit approach. 56
Stereotactic Body Radiation Therapy for thoracic nodes metastases, a multi-institutional experience 56
Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy 53
Reduction of inter-observer differences in the delineation of the target in spinal metastases SBRT using an automatic contouring dedicated system 52
Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time 52
Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes 49
Palliative radiotherapy in older adults with head and neck squamous cell carcinoma: A systematic review 48
SBRT for lymph node metastases from prostate cancer: a multi-institutional retrospective analysis 48
A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors: a comparison between two antipodal fractionations 47
SBRT FOR LYMPH NODE METASTASES FROM PROSTATE CANCER: A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS 47
Dose prescription in SBRT for early-stage non-small cell lung cancer: are we all speaking the same language? 45
Hypofractionated Postoperative Radiotherapy in Prostate Cancer with Ialuril Soft Gels®: Toxicity and Efficacy Analysis on a Retrospective Series of 305 Patients 45
Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer 44
The role of radiotherapy in patients with solid tumours after solid organ transplantation: a systematic review 44
Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity 43
Stereotactic Body Radiotherapy for a Rare Case of Sinonasal Metastasis Arising from Renal Cell Cancer 41
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 40
Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases 39
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 39
Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiation therapy 39
The Real Value of Stereotactic Ablative Radiotherapy (SABR) in Oligometastases: A Journey Into the Literature Evidence 39
Stereotactic body radiotherapy for oligometastatic castration sensitive prostate cancer using 1.5 T MRI-Linac: preliminary data on feasibility and acute patient-reported outcomes 39
Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac 38
Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 38
MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer 37
What is the role of reirradiation in the management of locoregionally relapsed non small-cell lung cancer? 36
SBRT for elderly oligometastatic patients as a feasible, safe and effective treatment opportunity 35
Stereotactic body radiotherapy (SBRT) and concomitant systemic therapy in oligoprogressive breast cancer patients 35
Linac-based versus MR-guided SBRT for localized prostate cancer: a comparative evaluation of acute tolerability 35
In reply to Simcock et al 34
Stereotactic Ablative radiation therapy (SABR) for cardiac arrhythmia: A new therapeutic option? 34
A comparative analysis between radiation dose intensification and conventional fractionation in neoadjuvant locally advanced rectal cancer: a monocentric prospective observational study 34
Mammary Chain Irradiation in Left-Sided Breast Cancer: Can We Reduce the Risk of Secondary Cancer and Ischaemic Heart Disease with Modern Intensity-Modulated Radiotherapy Techniques? 33
Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer 33
Prostate re-irradiation: current concerns and future perspectives 32
PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study 32
Stereotactic radiotherapy for oligometastases in the lymph nodes 32
Metastasis-directed Therapy (SBRT) Guided by PET-CT 18F-CHOLINE Versus PET-CT 68Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness 32
Oligometastatic sarcoma treated with Curative intent Ablative Radiotherapy (OSCAR): A multicenter study on behalf of AIRO (Italian association of Radiotherapy and clinical Oncology) 31
PSMA-PET/CT-Based Stereotactic Body Radiotherapy (SBRT) in the Treatment of Uncomplicated Non-Spinal Bone Oligometastases from Prostate Cancer 31
Post-HIFU locally relapsed prostate cancer: high-dose salvage radiotherapy guided by molecular imaging 31
Postoperative moderately hypofractionated radiotherapy in prostate cancer: a mono-institutional propensity-score-matching analysis between adjuvant and early-salvage radiotherapy 30
Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases 30
Long-term disease outcome and volume-based decision strategy in a large cohort of multiple brain metastases treated with a mono-isocentric linac-based Stereotactic Radiosurgery technique 29
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO 29
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis 29
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 28
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal’s letter to the editor 27
The predictive and prognostic role of metabolic and volume-based parameters of positron emission tomography/computed tomography as non-invasive dynamic biological markers in early breast cancer treated with preoperative systemic therapy 27
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 27
Prognostic value of two geriatric screening tools in a cohort of older patients with early stage Non-Small Cell Lung Cancer treated with hypofractionated stereotactic radiotherapy 27
Reirradiation on spine metastases: an Italian survey on behalf of palliative care and reirradiation study groups of Italian association of radiotherapy and clinical oncology (AIRO) 25
The use of SBRT in the management of oligometastatic gynecological cancer: report of promising results in terms of tolerability and clinical outcomes 23
Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START) 2
Totale 5.533
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/202252 4 0 0 14 0 1 0 9 3 5 14 2
2022/2023150 23 5 16 18 13 13 0 11 25 14 10 2
2023/202457 3 5 16 1 1 11 2 1 2 1 5 9
2024/2025842 2 13 11 3 2 101 144 64 83 201 94 124
2025/20264.322 237 359 1.613 333 94 124 456 607 143 186 156 14
Totale 5.533